$3.25 Million is the total value of Camber Capital Management LP's 41 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MYGN | MYRIAD GENETICS INC | $162,610 | +60.1% | 7,000,000 | 0.0% | 5.00% | +43.5% | |
| ZBH | ZIMMER BIOMET HOLDINGS INC | $161,500 | +1.3% | 1,250,000 | 0.0% | 4.97% | -9.1% | |
| SEM | SELECT MED HLDGS CORP | $124,080 | +4.1% | 4,800,000 | 0.0% | 3.82% | -6.7% | |
| PRGO | PERRIGO CO PLC | $89,675 | +5.2% | 2,500,000 | 0.0% | 2.76% | -5.6% | |
| XRAY | DENTSPLY SIRONA INC | $69,329 | +23.4% | 1,765,000 | 0.0% | 2.13% | +10.6% | |
| IONS | IONIS PHARMACEUTICALS INC | $68,800 | -5.4% | 1,925,000 | 0.0% | 2.12% | -15.2% | |
| BKD | BROOKDALE SR LIVING INC | $53,100 | +8.1% | 18,000,000 | 0.0% | 1.63% | -3.1% | |
| MRTX | MIRATI THERAPEUTICS INC | $52,052 | -17.9% | 1,400,000 | 0.0% | 1.60% | -26.4% | |
| QTRX | QUANTERIX CORP | $38,600 | -18.6% | 3,425,000 | 0.0% | 1.19% | -27.0% | |
| OSUR | ORASURE TECHNOLOGIES INC | $25,713 | +25.5% | 4,250,000 | 0.0% | 0.79% | +12.5% | |
| COLL | COLLEGIUM PHARMACEUTICAL INC | $25,190 | +3.4% | 1,050,000 | 0.0% | 0.78% | -7.2% | |
| GKOS | GLAUKOS CORP | $17,535 | +14.7% | 350,000 | 0.0% | 0.54% | +2.9% | |
| NSTG | NANOSTRING TECHNOLOGIES INC | $14,850 | +24.2% | 1,500,000 | 0.0% | 0.46% | +11.5% | |
| PBYI | PUMA BIOTECHNOLOGY INC | $13,086 | -27.0% | 4,235,000 | 0.0% | 0.40% | -34.5% | |
| BROOKDALE SR LIVING INCunit 11/15/2023 | $11,583 | +4.7% | 250,000 | 0.0% | 0.36% | -6.1% | ||
| SOLID BIOSCIENCES INC | $6,723 | -11.9% | 1,418,439 | 0.0% | 0.21% | -21.0% | ||
| CANO | CANO HEALTH INC | $3,640 | -33.6% | 4,000,000 | 0.0% | 0.11% | -40.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEVA PHARMACEUTICALS INDS LTD | 34 | Q3 2023 | 9.7% |
| BROOKDALE SR LIVING INC | 32 | Q3 2023 | 5.0% |
| PERRIGO CO PLC | 29 | Q3 2023 | 7.1% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 8.5% |
| NEKTAR THERAPEUTICS | 28 | Q1 2022 | 9.8% |
| UNIVERSAL HLTH SVCS INC | 25 | Q3 2023 | 9.9% |
| MYRIAD GENETICS INC | 24 | Q3 2023 | 5.0% |
| SAREPTA THERAPEUTICS INC | 23 | Q3 2023 | 6.0% |
| MYLAN NV | 21 | Q3 2020 | 10.1% |
| AMAG PHARMACEUTICALS INC | 21 | Q3 2020 | 4.0% |
View Camber Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC | February 02, 2023 | ? | ? |
| Solid Biosciences Inc. | December 12, 2022 | ? | ? |
| AVROBIO, Inc. | February 14, 2022 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 14, 2022 | ? | ? |
| AMAG PHARMACEUTICALS, INC. | February 16, 2021 | ? | ? |
| Atara Biotherapeutics, Inc. | February 16, 2021 | ? | ? |
| Change Healthcare Inc. | February 16, 2021 | ? | ? |
| GLYCOMIMETICS INC | February 16, 2021 | ? | ? |
| Clovis Oncology, Inc. | February 14, 2020 | ? | ? |
| Cyclerion Therapeutics, Inc. | February 14, 2020 | ? | ? |
View Camber Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-30 |
| 13F-HR | 2023-08-14 |
View Camber Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.